Form 8-K - Current report:
SEC Accession No. 0001437749-25-005242
Filing Date
2025-02-26
Accepted
2025-02-26 16:34:30
Documents
15
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlry20250226_8k.htm   iXBRL 8-K 32933
2 EXHIBIT 10.1 ex_782816.htm EX-10.1 790000
  Complete submission text file 0001437749-25-005242.txt   1106685

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20250221.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlry-20250221_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20250221_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20250221_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT tlry20250226_8k_htm.xml XML 2830
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 25670717
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)